Sponsored by:

EuroPCR 2012

EuroPCR | May 15-18, 2012

EuroPCR 2012
Note that some of these links take you to a site outside of CardioSource.
CardioSource does not assume responsibility for content of external sites.

Friday May 18 2012

  • Biodegradable Stents Hold Up

    PARIS — The next generation of drug-eluting stents that do a disappearing act, whether with a biodegradable polymer or an entirely bioabsorbable platform, appears to be holding up to conventional stents over the short term.

  • 'Parachute' Promising for Heart Failure

    PARIS — A percutaneous device that walls off part of the left ventricle to help failing hearts appears to have a big impact on outcomes, pilot study results showed.

  • Bigger BP Drop Goal for Renal Denervation

    PARIS — More dramatic blood pressure reductions may be on the horizon for patients with resistant hypertension given the phalanx of renal denervation systems under development.

Thursday May 17 2012

  • Statins Before Stenting Cut Risks

    PARIS — Statin treatment before percutaneous coronary intervention reduces cardiac injury from the procedure and boosts longer- term outcomes, Italian researchers affirmed.

  • 'Virtual Stenting' Aids PCI Planning

    PARIS — Computer projections of the impact of stenting on cardiac ischemia measured by a specialized CT imaging technique appear accurate and could help with planning out placement, researchers found.

Wednesday May 16 2012

  • Valve-in-Valve TAVI Tricky, But It Works

    PARIS — Transcatheter replacement of failing bioprosthetic aortic valves is usually successful but likely should be left to the most expert hands, researchers suggested.

  • Novel Stent Safer in MI

    PARIS — A novel drug-eluting stent appears to substantially improve outcomes for heart attack patients more than a bare-metal stent, researchers found.

Tuesday May 15 2012

  • Ischemia-Guided Stenting Beats Meds Alone

    PARIS — For patients with proven ischemia, stenting substantially cuts the revascularization rate compared with optimal medical therapy alone, preliminary trial results showed.

Monday May 14 2012

  • Fractional Flow in Focus at EuroPCR

    PARIS — Ischemia-guided therapy for multivessel coronary artery disease interventions may be the show-stealer at this year's EuroPCR meeting here.

Advertisement
Advertisement